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The present study examined the effect of GTP-7-S on the function of insulin receptors partially purified from adult rat cardiomyocytes by WGA 
chromatography. GTP-y-S increased receptor autophosphorylation about two times and fully mimicked the stimulatory action of insulin on 
poly(Glu:Tyr) phosphorylation with no additional effect of the hormone. The effect of GTP-T-S was specific, dose-dependent. and due to an increase 
in the V,,, of the kinase. In the presence of ATP or AMP-PNP, insulin significantly enhanced the binding of [%]GTP-y-S to the partially purified 
insulin receptor. The findings suggest coupling of the insulin receptor to a G-protein which may be involved in the regulation of tyrosine kinase 
activity. 
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1. I~RODUCTION 
In the past few years evidence has accumulated which 
suggests that insulin receptor signalling may involve 
coupling to GTP-binding proteins [l-7]. This view is 
mainly supported by the effects of cholera and pertussis 
toxin on insulin action. Thus, cholera toxin was found 
to modify insulin signalling in the liver [l] and in the 
heart [7], whereas pertussis toxin attenuates the activa- 
tion of hexose transport and the generation of inosi- 
tolglycan mediators in BC,H-1 myocytes [3], and the 
antilipolytic activity of insulin in adipocytes [Z]. More 
recently it was found that insulin increases GTP-bind- 
ing to plasma membranes from fat and muscle cells [8,9] 
and that this binding occurs at a 40141 kDa membrane 
protein very similar or identical to G, [9,10]. However, 
an effector system which couples to this G-protein spe- 
cies has not been identified until now. 
Recently, Srivastava and Singh [l l] reported the co- 
purification of a GTP-binding protein with the insulin 
recptor, supporting the notion [12,13] that the insulin 
receptor is associated with G-proteins which regulate 
receptor functions. However, controversial findings 
have been reported concerning this hypothesis. Thus, 
Davis and McDonald [13] showed that the tyrosine ki- 
nase activity of the partially purified insulin receptor 
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from adipose tissue is inhibited by GTP-y-S; however, 
this finding has not been reproduced by Kellerer et al. 
[9] using the same tissue. Furthermore, pertussis toxin 
had no effect on the autophosphorylation and tyrosine 
kinase activity of the insulin receptor in BC3H-1 my- 
ocytes [Xl, whereas GTP-)I-S decreased insulin-mediated 
phosphorylation of endogenous proteins in L 6 muscle 
cells [14]. Interestingly, no activation of insulin receptor 
kinase by GTP-)I-S has been reported so far, although 
GTP-r-S can induce tyrosine phosphorylation in other 
systems [151. 
In the light of our recent observations of G-protein- 
mediated insulin signalling in isolated ventricular cardi- 
omyocytes [7] we have now investigated the effects of 
GTP-)I$ on the functional activity of insulin receptors 
solubilized from these cells. The data suggest hat car- 
diac insulin receptors are coupled to a G-protein which 
may act as a regulator of tyrosine kinase activity. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
[y-“‘P]ATP (6,000 Cilmmol) and [%]GTP-y-S (1,200 Cilmmol) 
were purchased from New England Nuclear (Germany). Reagents for 
SDS-PAGE were supplied by Pharmacia and Sigma (Germany). Tri- 
ton X- 100, poly(Glu:Tyr) 4: 1, DTT, GTP-F-S, GDP-&S, WGA cou- 
pled to agarose, phenylmethylsulfonyl fluoride and aprotinin were 
from Sigma (Germany). Bacitracin, leucine, benzamidine, Ieupeptin 
and pepstatin were obtained from Fluka (Switzerland). Pig monocom- 
ponent insulin was from Novo (Denmark). All other chemicals were 
of the highest grade commercially available. 
2.2. Solubilkation of insuhn receptors and partial purification 
Male Wistar rats fed ad libitum and weighing 280-320 g were used 
in all experiments. Ca’+-tolerant myocytes were isolated by perfusion 
of the heart with collagenase as previously described by us 1161. Solu- 
bilization and purification of insulin receptors from these cells was 
performed according to Hlring et al. [I 71 with modifications. 0.7-I x 
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10’ cells were used for each receptor preparation. Cell lysis was 
achieved by freezing and thawing (three times) the cells in a phosphate 
buffer (composition NaH,PO, 10 mM, sucrose 250 mM, EDTA 5 
mM, glycerol lo%, pH 7.5) containing the protease inhibitors ben- 
zamidin (10 mM), phenylmethylsulfonyl fluoride (5 mM), leupeptin 
(2 PM), pepstatin (2 PM), aprotinin (1.2 trypsin inhibiting U/ml), 
bacitracin (O.Ol%), and leucine (10 mM). The cell lysate was then 
centrifuged for 50 min at 20,000 x g and the pellet was solubilized for 
90 min in HEPES buffer (composition HEPES 25 mM, Triton X-100 
I%, phenylmethylsulfonyl fluoride 2 mM, leupeptin 2 PM, pepstatin 
2 PM, aprotinin 0.6 trypsin inhibiting U/ml, pH 7.5). Elution buffer 
(composition HEPES 25 mM, NaCl 120 mM, KC1 5 mM, CaClz 1 
mM, MgSO, 0.8 mM, glycerol 10%) was added to a volume of 10 ml, 
and this material was centrifuged for 90 min at 100,000 x g. The 
supematant was diluted 5 times with elution buffer and applied to a 
column of WGA coupled to agarose. After washing the column with 
50 ml of elution buffer, the bound material was eluted with elution 
buffer containing 0.3 M N-acetylglucosamine. The fraction containing 
insulin binding activity was frozen in liquid nitrogen and stored at 
-80°C. Protein was determined using a modification of the Bio-Rad 
protein assay with BSA as a standard. 15-20 pg glycoprotein was 
obtained from lo6 cardiac cells. 
2.3. Autophosphorylation of the partially puriJied insulin receptor 
3-5 pg of the WGA-purified insulin receptor was incubated for 30 
min at 25°C in the absence or presence of the indicated additions in 
a final volume of 30 ~1 in phosphorylation buffer (HEPES 25 mM, 
MgClz 10 mM, MnCl, 5 mM, Na,VO, 0.3 mM, pH 7.5). The reaction 
was initiated by adding 10 ,&i of [Y-~*P]ATP (final concentration 28 
PM) and conducted for 10 min. The incubation was terminated by 
addition of 10 ~1 of Laemmli [18] sample buffer (250 mM Tris, 8% 
SDS, 20% glycerol, and 0.04% Bromphenol blue), containing 1 mM 
ATP and 200 mM DTT. and boiling for 10 min. Phosphoproteins were 
analyzed by SDS-PAGE using 4% stacking and 7% resolving gels. The 
gels were subjected to autoradiography using Kodak X-Omat AR film 
and intensifying screens. Autoradiographs were quantified by laser- 
scanning densitometry. Significance of reported differences was evalu- 
ated by using the null hypothesis and t statistics for paired data. 
2.4. Assay of tyrosine kinase activity 
Aliquots (0.61 pg) of the partially purified insulin receptor were 
preincubated in phosphorylation buffer (final volume 65~1) for 30 min 
at 25’C in the absence or presence of the indicated additions. Incuba- 
tion was then continued for 30 min in the absence or presence of 
insulin (3.2 x lo-’ M). The phosphorylation reaction was started by 
addition of [y-32P]ATP (6 PCi, final concentration 50 PM) and the 
exogenous ubstrate poly(Glu:Tyr) (0.2 mg/ml). The reaction was al- 
lowed to proceed for 20 min and was terminated by addition of 50 mM 
unlabelled ATP and applying triplicate aliquots (IO@) onto Whatman 
P81 filter papers. The filter papers were extensively washed in 10% 
trichloroacetic acid containing 10 mM sodium pyrophosphate, dried, 
and radioactivity counted by liquid scintillation. Non-specifically 
bound radioactivity was defined as that bound to the filters in the 
absence of poly(Glu:Tyr) and was subtracted from that bound in the 
presence of poly(Glu:Tyr). 
2.5. GTP-y-S binding assay 
Binding of [35S]GTP-y-S to WGA-purified proteins was determined 
by incubating 0.5-l pg glycoprotein in phosphorylation buffer at 25°C 
in a final volume of 100 yl. After preincubating the protein solution 
for 30 min in the absence or presence of insulin, the binding reaction 
was initiated by the addition of 1 ,&i [“S]GTP-y-S (final concentra- 
tion 10 nM) and terminated at the indicated times by the addition of 
2 ml of ice-cold stop solution (Tris 20 mM, NaCl 100 mM, MgCl, 25 
mM, pH 8.0) followed by rapid filtration through B85 nitrocellulose 
filters (Schleicher & Schuell). The filters were washed with 7 ml stop 
solution, dried and placed into 10 ml of scintillation fluid. Radioactiv- 
ity was then determined in a Beckman LS 6000 IC scintillation 
counter. All experiments were performed in triphcate. Non-specific 
binding was determined in parallel incubations in the presence of 100 
,uM unlabelled GTP. All binding data reported represent specific bind- 
ing defined as the difference between total and non-specific binding. 
3. RESULTS 
Preincubation of the partially purified insulin recep- 
tor with GTP-y-S resulted in an increased incorporation 
of 32P into the 95 kDa j&subunit of the insulin receptor 
(Fig. 1). As presented in Table I, the nucleotide in- 
creases autophosphorylation about two times, reaching 
about one half of the stimulatory action of insulin ob- 
tained at maximal concentrations of the hormone. It 
may be argued that the effect of GTP-)I-S is related to 
elevated ATP concentrations during the incubation pe- 
riod due to an inhibition of nucleotidase activity. How- 
ever, under all incubation conditions no significant al- 
teration of the total ATP concentration (50 PM) could 
be detected using the firefly luciferase assay [7]. 
In order to elucidate if the GTP-y-S-induced increase 
in autophosphorylation of the insulin receptor leads to 
an increased tyrosine kinase activity, we have studied 
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Fig. 1. Effect of GTP-y-S on insulin receptor autophosphorylation. 
3-5 pg of partially purified insulin receptor were preincubated for 30 
min in the absence or presence of GTP-y-S (200 PM). Incubation was 
then continued for an additional 30 min in the absence or presence of 
insulin (3.5 x IO-’ M). The phosphorylation reaction was initiated by 
adding 28 PM [32P]ATP and conducted for 10 min. Phosphoproteins 
were separated by SDS-PAGE and subjected to autoradiography. A
representative autoradiogram of three separate xperiments i shown. 
Table I 
Effect of insulin and GTP-y-S on insulin receptor b-subunit auto- 
phosphotylation 
Incubation conditions /7-subunit autophosphorylation 
(% of maximum) 
Basal 21.5 f 3.9 
Insulin 88.7 f 11.2 
GTP-y-S 38.7 ? 8.9* 
Insulin + GTP-y-S 97.5 f 2.5 
Experimental conditions are described in the legend to Fig. 1. The 
relative amount of/I-subunit autophosphorylation was determined by 
laser-scanning densitometry of individual autoradiograms. Mean val- 
ues (% of maximum) of three separate experiments (fS.E.M.) are 
shown. 
*Significantly different from basal with P < 0.05. 
(E2) 73 
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the effect of the nucleotide on insulin stimulated phos- 
phorylation of the synthetic substrate poly(Glu:Tyr), 
reflecting the intrinsic tyrosine kinase activity of the 
receptor. As presented in Fig. 2, preincubation with 
GTP-y-S (100 PM) fully mimicked the stimulatory ac- 
tion of insulin on poly(Glu:Tyr) phosphorylation. 
Under these conditions no significant effect of the 
hormone on poly(Glu:Tyr) phosphorylation could be 
detected, suggesting that GTP-)I-S stimulates the insulin 
receptor kinase in an insulin-like fashion. In contrast, 
the pyrimidine triphosphate, CTP, did not influence 
basal and insulin stimulated poly(Glu:Tyr) phosphoryl- 
ation. 
The effect of GTP-y-S was dose-dependent, with a 
maximal effect of the nucleotide at 100pM (Fig. 3). The 
stimulatory action of GTP-)I-S persisted even up to 1 
mM. GDP-/?-S, an antagonist of G-protein-mediated 
functions, was without effect on poly(Glu:Tyr) phos- 
phorylation. To further characterize the mechanism of 
GTP action, the ATP concentration was varied in the 
range of 12.5 ,uM up to 200 ,uM. Lineweaver-Burk 
analysis of the phosphorylation of the synthetic pol- 
ypeptide in the absence or presence of GTP-y-S (100 
PM) showed that the K,,, of the partially purified insulin 
receptor for poly(Glu:Tyr) phosphorylation was not 
significantly affected by GTP-)I-S (43 and 54.1 PM for 
control and GTP-y-S, respectively). However, the l~‘,,~ 
increased from 1.88 to 3.46 pmol/,ug protein x 20 min 
when preincubating the receptor with GTP-T-S. This 
agrees with the well-established effect of insulin on insu- 
lin receptor tyrosine kinase activity, which is exclusively 
due to an increase in V,,, [19]. 
The effects of GTP-y-S on the function of solubilized 
insulin receptors may involve either a direct interaction 
o- 
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Fig. 2. Effect of GTP-)I-S and CTP on exogenous ubstrate protein 
kinase activity of the WGA-agarose-purified insulin receptor. Ahq- 
uots (0.61 pup) of the glycoprotein fraction were preincubated for 30 
min in the absence (control) or presence of GTP-y-S (100 PM) or CTP 
(100 PM). Incubation was then continued for 30 min in the absence 
or presence of insulin (3.2 x 10e7 M). Poly(Glu:Tyr) (0.2 mg/ml) phos- 
phorylation was then determined using 50 PM ATP as described in 
section 2. Data are means ? S.E.M. obtained from three independent 
receptor preparations. 
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Fig. 3. Effect of GTP-Y-S concentration on exogenous ubstrate pro- 
tein kinase activity. Partially purified insulin receptor was preincu- 
bated with the indicated concentrations of guanosine nucleotides for 
30 min. Kinase activity was then determined as outlined in Fig. 2. 
Values are means + S.E.M. (n = 34). *Significantly different from 
control with P c 0.05. 
of the receptor with the nucleotide or a GTP-binding 
protein closely coupled to the receptor. Since hormone 
receptors which couple to G-proteins increase the bind- 
ing of GTP, we have studied the effect of insulin on the 
time course of [35S]GTP-y-S binding to WGA-purified 
proteins. As shown in Fig. 4 (upper panel), insulin sig- 
nificantly enhanced GTP-y-S binding with a most 
prominent effect (196% of control) at early time points. 
When ATP was removed from the incubation medium 
(Fig. 4, middle panel), the effect of insulin was no longer 
detectable. In order to elucidate if autophosphorylation 
of the insulin receptor B-subunit may be essential for 
coupling to the G-protein system, a similar experiment 
was performed, substituting ATP by the non-hydrolyza- 
ble analogue, AMP-PNP. As presented in Fig. 4 (lower 
panel), the effect of ATP can be fully mimicked by 
AMP-PNP, suggesting that the insulin receptor inter- 
acts with the G-protein in a tyrosine kinase-independent 
fashion. 
4. DISCUSSION 
Originally it was thought that coupling to GTP-bind- 
ing proteins is exclusively limited to hormone receptors 
with several membrane spanning domains [20]. How- 
ever, more recent studies suggest hat single-spanning 
receptors, like epidermal growth factor receptor [21], 
insulin-like growth factor-I [22] and -11 [23] receptor, 
and insulin receptor, may also be coupled to G-proteins. 
In the latter case, the situation may be even more com- 
plex. Thus, GTP-binding proteins have been suggested 
to be involved in insulin signalling both at the receptor 
[9,13,24] and the post-receptor level [7,14,25]. The iden- 
tity of the G-proteins and the functional implications, 
however, remain poorly understood. 
c 
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Fig. 4. Effect of insulin on [“S]GTP-y-S binding to WGA-purified 
proteins. Glycoprotein (0.5-l pg) was incubated for 30 min at 25°C 
in the absence (0) or presence (M) of insulin (1 PM). 1 ,Ki [“S]CiTP-r-S 
(final concentration 10 nM) was then added and binding was meas- 
ured as detailed in section 2. All data have been corrected for non- 
specific binding. (Upper panel) All incubations were performed in the 
presence of ATP 50 PM). (Middle panel) No adenosine nucleotide 
present. (Lower panel) All incubations were performed in the presence 
of AMP-PNP (500 PM). Values are means f S.E.M. of 334 receptor 
preparations. *Not significantly different from control with P > 0.05. 
In the present investigation we have used insulin re- 
ceptors solubilized from ventricular cardiomyocytes in 
order to test the hypothesis that the insulin receptor is 
closely coupled to a G-protein, which may operate as 
a regulator of insulin receptor functions. A major find- 
ing is the observation that GTP-y-S increases auto- 
phosphorylation, and most probably thereby activates 
the tyrosine kinase activity of the receptor preparation. 
Several lines of evidence suggest that the nucleotide 
mimicks the effect of insulin on the tyrosine kinase ac- 
tivity of the isolated insulin receptor. First, GTP-y-S 
increased poly(Glu:Tyr) phosphorylation to the level 
observed with insulin; second, no additive effect of the 
hormone could be detected; and third, GTP-y-S in- 
creased the I’,,,,, of the kinase in agreement with the 
effect of insulin [19]. 
In contrast to our findings, Davis and McDonald 
[13], using adipocyte insulin receptors, recently reported 
on an inhibition of B-subunit autophosphorylation and 
a reduction of tyrosine kinase activity by GTP-7-S at 
high concentrations of the nucleotide. Furthermore, 
Kellerer et al. [9] described an inhibition of insulin- 
stimulated receptor kinase activity by GTP-y-S in adi- 
pocyte plasma membrane preparations. The apparent 
discrepancy between these studies and our results may 
be explained by very recent observations from Mc- 
Donald’s group, published in abstract form [26], in 
which it was shown that placenta insulin receptors are 
associated with a 67 and a 41 kDa G-protein. Removal 
of the 67 kDa G-protein increases the tyrosine kinase 
activity, whereas the 41 kDa G-protein is suggested to 
be responsible for insulin sensitivity of the kinase. Since 
the purification protocol may affect the amount and the 
nature of G-proteins associated with the insulin recep- 
tor, differing results concerning kinase regulation are 
not surprising. Preliminary photolabeling experiments 
in our laboratory have shown that the purified insulin 
receptor preparation indeed contains a variety of G- 
proteins, but only one species is activated by insulin. In 
light of the above mentioned observations [26] our data 
would be compatible with the dissociation of a G-pro- 
tein from the receptor upon addition of GTP-y-S. fi- 
nally leading to a kinase activation. 
The assumption that GTP-y-S binds to a G-protein 
and not to the insulin receptor itself is supported by 
earlier work showing that GTP has no effect on highly 
purified insulin receptor preparations [27]. Additional 
evidence for the functional relationship between the 
WGA-purified insulin receptor and a G-protein is ob- 
tained from the studies on [35S]GTP-y-S binding. Insu- 
lin increased GTP-)I-S binding under conditions which 
are required for insulin signalling, suggesting that the 
insulin receptor is closely coupled, most probably asso- 
ciated with a G-protein. Consistently, the co-purifica- 
tion of G-proteins with the insulin receptor has been 
reported by several groups [ 11,261. 
Insulin receptor/G-protein coupling was observed in 
(E4) 7.5 
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the presence of ATP or AMP-PNP, but could not be 
detected in the absence of these nucleotides. This find- 
ing suggests that the communication between the insulin 
receptor and the G-protein system does not involve au- 
tophosphorylation of the insulin receptor. However, in- 
sulin signalling appears to be dependent on the presence 
of ATP, most probably on the binding of the nucleotide 
to the /?-subunit of the insulin receptor. The latter find- 
ing agrees well with a recent report by Maddux and 
Goldfine [28] showing that insulin plus ATP may induce 
a conformational change in the p-subunit without in- 
ducing receptor autophosphorylation. In light of our 
findings it may be speculated that conformational 
changes of the insulin receptor result in a non-covalent 
interaction with G-proteins. Furthermore, in this model 
of non-covalent insulin receptor/G-protein coupling, a 
G-protein-mediated activation of the insulin receptor 
tyrosine kinase by insulin would represent a putative 
pathway of insulin signalling in target cells. This hy- 
pothesis, although still highly speculative, needs further 
attention. 
Taken together, the present study supports the notion 
that the insulin receptor interacts with a G-protein and 
that this interaction modulates receptor functions. 
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